Cargando…

Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma

MicroRNAs function as oncomiRs and tumor suppressors in diverse cancers. However, the utility of specific microRNAs in predicting the clinical benefit of chemotherapy has not been well-established. Here, we investigated the correlation between microRNA-21 expression and hepatic arterial infusion che...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiaodong, Li, Jingjing, Guo, Weidong, Liu, Wei, Yu, Jia, Song, Wei, Dong, Lei, Wang, Fang, Yu, Shuangni, Zheng, Yi, Chen, Songsen, Kong, Yan, Liu, Changzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385853/ https://www.ncbi.nlm.nih.gov/pubmed/25544773

Ejemplares similares

RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma
por: Huang, Hechen, et al.
Publicado: (2018)

RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis
por: Shi, Hongwei, et al.
Publicado: (2023)

Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary results
por: Bai, Mingjun, et al.
Publicado: (2019)

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
por: Tomimaru, Y, et al.
Publicado: (2010)

MicroRNA‐21 induces 5‐fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4
por: Wei, Xueju, et al.
Publicado: (2016)

Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases.
por: Ramirez, L. H., et al.
Publicado: (1993)

Membrane Transport and Antitumor Activity of Pirarubicin, and Comparison with Those of Doxorubicin
por: Sugiyama, Tomomi, et al.
Publicado: (1999)

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients
por: Wu, Lina, et al.
Publicado: (2015)

MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: A systematic review and meta-analysis
por: Qu, Juan, et al.
Publicado: (2019)

Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
por: Wen, Xue, et al.
Publicado: (2019)

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2020)

In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
por: Chen, Gang, et al.
Publicado: (2012)

Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2015)

Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer
por: Jiang, Bo, et al.
Publicado: (2017)

Characteristics of the Inhibitory Effect of Mitoxantrone and Pirarubicin on Lung Metastases of Colon Carcinoma 26
por: Iigo, Masaaki, et al.
Publicado: (1995)

Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E
por: Zhang, Ying, et al.
Publicado: (2021)

Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells
por: del Mar Díaz-González, Sacnite, et al.
Publicado: (2019)

Reducing oxidative stress may be important for treating pirarubicin-induced cardiotoxicity with schisandrin B
por: Tang, Heng, et al.
Publicado: (2022)

Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin
por: Liu, Weifang, et al.
Publicado: (2021)

Retracted: Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

MicroRNA‐129‐1‐3p protects cardiomyocytes from pirarubicin‐induced apoptosis by down‐regulating the GRIN2D‐mediated Ca(2+) signalling pathway
por: Li, Qi, et al.
Publicado: (2020)

Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
por: Wang, Hongwei, et al.
Publicado: (2014)

Exosomal microRNAs in hepatocellular carcinoma
por: Liu, Chenbin, et al.
Publicado: (2021)

Possibility of Contribution of Nucleoside Transport Systems to Pirarubicin Uptake by HL60 Cells but Not Mononuclear Cells
por: Nagasawa, Kazuki, et al.
Publicado: (1998)

Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia
por: Lv, Suqin, et al.
Publicado: (2019)

Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis
por: Chen, Da-Yin, et al.
Publicado: (2020)

Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report
por: Kato, Yutaka, et al.
Publicado: (2023)

Long non-coding RNA MCM3AP-AS1 facilitates colorectal cancer progression by regulating the microRNA-599/ARPP19 axis
por: Yu, You, et al.
Publicado: (2021)

Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis
por: Liu, Yiwen, et al.
Publicado: (2019)

MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2015)

Curcumin Inhibits Hepatocellular Carcinoma via Regulating miR-21/TIMP3 Axis
por: Li, Jingtao, et al.
Publicado: (2020)

MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis
por: Sun, Wei, et al.
Publicado: (2016)

Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma
por: Wang, Ji Yu, et al.
Publicado: (2017)

Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma
por: ZENG, YAN-PING, et al.
Publicado: (2014)

Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways
por: Zhang, Yang, et al.
Publicado: (2023)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019)

MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer
por: Xu, Fei, et al.
Publicado: (2020)

Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study
por: Zhao, Guang Sheng, et al.
Publicado: (2021)

The MicroRNA-551a/MEF2C Axis Regulates the Survival and Sphere Formation of Cancer Cells in Response to 5-Fluorouracil
por: Kang, Hoin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fdg6rrv9dh632ml6fl61l1mo10